@prefix this: <
http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM
> .
@prefix sub: <
http://purl.org/np/RAprLrmA-9l2aniqy4JjFhlX_hYPl6eplJwBxZhMSKxBM#
> .
@prefix np: <
http://www.nanopub.org/nschema#
> .
@prefix dct: <
http://purl.org/dc/terms/
> .
@prefix rdf: <
http://www.w3.org/1999/02/22-rdf-syntax-ns#
> .
@prefix nt: <
https://w3id.org/np/o/ntemplate/
> .
@prefix xsd: <
http://www.w3.org/2001/XMLSchema#
> .
@prefix rdfs: <
http://www.w3.org/2000/01/rdf-schema#
> .
@prefix orcid: <
https://orcid.org/
> .
@prefix bl: <
https://w3id.org/biolink/vocab/
> .
@prefix nkg: <
https://w3id.org/um/neurodkg/
> .
@prefix prov: <
http://www.w3.org/ns/prov#
> .
@prefix npx: <
http://purl.org/nanopub/x/
> .
sub:Head
{
this:
np:hasAssertion
sub:assertion
;
np:hasProvenance
sub:provenance
;
np:hasPublicationInfo
sub:pubinfo
;
a
np:Nanopublication
.
}
sub:assertion
{
<
http://purl.obolibrary.org/obo/MONDO_0005146
>
bl:category
bl:Disease
.
sub:association
rdf:object
<
http://purl.obolibrary.org/obo/MONDO_0005146
> ;
rdf:predicate
bl:treats
;
rdf:subject
<
https://go.drugbank.com/drugs/DB01221
> ;
a
rdf:Statement
;
rdfs:label
"The most commonly reported diagnosis treated was Major Depressive Disorder (72.2%), followed by Bipolar Disorder (15.1%), and Posttraumatic Stress Disorder (5.7%). Most providers (87.7%) reported administering ketamine via an intravenous route, with a minority reporting using an oral (22.8%) or an intranasal (19.3%) formulation." ;
bl:association_type
bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation
;
bl:has_population_context
sub:cohort
;
bl:provided_by
<
https://w3id.org/um/NeuroDKG
> ;
bl:publications
<
https://pubmed.ncbi.nlm.nih.gov/28669202/
> ;
bl:relation
nkg:OffLabelIndication
.
sub:cohort
rdfs:label
"Adults" ;
bl:category
bl:Cohort
.
<
https://go.drugbank.com/drugs/DB01221
>
bl:category
bl:Drug
.
}
sub:provenance
{
sub:assertion
prov:wasAttributedTo
orcid:0000-0002-7641-6446
.
}
sub:pubinfo
{
sub:sig
npx:hasAlgorithm
"RSA" ;
npx:hasPublicKey
"MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" ;
npx:hasSignature
"WH66EBsnd4zOO1bx41pXZ3m1X0NAuyd8VYukTK7n1HS6FwCiSvgUCH9SHtB+1kg8sD+PpaZsalHT45SZNno4GqaEkTfCl6vkKZ2Uu7hmZO/rMqsKPaFwF3Oo9HStTeswegs06TyzPgaPwzfVhoznPmBfhPgfxRQ6+8vXpbQ+9+E=" ;
npx:hasSignatureTarget
this:
.
this:
dct:created
"2021-05-25T14:42:02.095+02:00"^^
xsd:dateTime
;
dct:creator
orcid:0000-0002-7641-6446
;
nt:wasCreatedFromProvenanceTemplate
<
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
> ;
nt:wasCreatedFromPubinfoTemplate
<
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
> ;
nt:wasCreatedFromTemplate
<
http://purl.org/np/RAZdZj78B6nKrP1Q00oFzsK07u7WdiY3sToz-H-H2nSgg
> .
}